Skip to Content

BAYER 40 (Stivarga 40 mg)

Generic Name: regorafenib

Pill imprint BAYER 40 has been identified as Stivarga 40 mg.

Stivarga is used in the treatment of colorectal cancer; gastrointestinal stromal tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Stivarga 40 mg is not a controlled substance under the Controlled Substance Act (CSA).

Stivarga 40 mg BAYER 40
Discount Card Promo
Stivarga
Generic Name:
regorafenib
Imprint:
BAYER 40
Strength:
40 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Bayer HealthCare Pharmaceuticals Inc.
National Drug Code (NDC):
50419-0171
Inactive Ingredients:
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
silicon dioxide
ferric oxide red
ferric oxide yellow
soya lecithin
polyethylene glycol 3350
polyvinyl alcohol
magnesium silicate
titanium dioxide
povidone

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide